HIIT and Metabolic Health: What the 2025 Meta-Analyses Added

HIIT has become firmly embedded in fitness culture as the symbol of "effective short workouts." The problem is that behind this brand lie dozens of different protocols with different outcomes. By 2025, enough randomized trials had accumulated to conduct serious meta-analyses and clarify: what HIIT actually does to the cardiovascular system and metabolism, and to what extent it surpasses regular cardio — if it does at all.

What is HIIT and how does it differ from regular cardio?

HIIT (High-Intensity Interval Training) alternates work intervals at 80–95% of maximum heart rate with periods of active or passive recovery. A typical work interval lasts from 20 seconds to 4 minutes; the total session duration is 15–30 minutes including warm-up.

Moderate continuous cardio (MICT) operates in the 55–70% of maximum heart rate zone without breaks; a typical session lasts 30–60 minutes. The key difference is not only intensity but also total volume: HIIT sessions are considerably shorter. The question the 2025 meta-analyses addressed: does intensity compensate for the lack of volume?

Cardiovascular effects: what 14 RCTs found

The meta-analysis by Li and Dong, published in Frontiers in Physiology (December 2025), pooled 14 randomized clinical trials with 500 participants — all sedentary adults. Blood pressure results were statistically significant: systolic pressure decreased by an average of 5.02 mmHg (95% CI: -7.29 to -2.76), diastolic by 2.35 mmHg (95% CI: -4.49 to -0.21).

Vascular function, measured via flow-mediated dilation (FMD), improved with an effect size of SMD = 1.12 (95% CI: 0.32–1.92) — a large effect. FMD reflects the endothelium's ability to dilate blood vessels in response to increased blood flow and is considered an early marker of cardiovascular risk. In individual studies, VO2max increased by 9–21% depending on the protocol and baseline fitness.

Arterial stiffness (pulse wave velocity, PWV) showed no significant improvement — the difference was -0.20 (95% CI: -0.60 to 0.21), a statistically null effect. The authors note an insufficient number of studies on this marker.

Metabolic health: HIIT versus moderate cardio

The meta-analysis by Lu, Baker, Ying, and Lu, published in Frontiers in Endocrinology (January 2025), focused on 20 RCTs with 738 participants, examining low-volume HIIT (LV-HIIT). Compared to a no-exercise control group: fasting glucose decreased by 16.63 mg/dL (95% CI: -25.30 to -7.96), HbA1c by 0.70% (95% CI: -1.10 to -0.29). Both results are statistically significant.

Comparison with moderate cardio (MICT): for insulin sensitivity, LV-HIIT was significantly better (SMD = -0.40, 95% CI: -0.70 to -0.09, p = 0.01). For fasting glucose, insulin, and HbA1c levels, the difference between groups did not reach statistical significance — meaning both methods yield similar glycemic results.

The authors' key practical conclusion: LV-HIIT requires approximately four times less training time than MICT, with comparable impact on glycemia. For time-pressed individuals, this is a meaningful advantage.

Limitations: when is HIIT not suitable?

The data were obtained primarily from sedentary adults without significant pathology. Extrapolation to people with cardiovascular disease, arrhythmias, orthopedic limitations, or decompensated diabetes requires caution and medical supervision. PWV did not improve, suggesting possible limitations of HIIT for arterial stiffness.

The number of studies in each meta-analysis is small (14 and 20 RCTs), and protocols are heterogeneous: "HIIT" in different trials means different work and recovery regimes, different types of exercise (cycle ergometer, running, rowing). This makes precise dosing recommendations difficult. Injury risk in untrained individuals at high intensity is a real risk factor that is often not tracked in meta-analyses.